| Name | Title | Contact Details |
|---|
Unlock Your Business Creativity with AI-accelerated Content Productivity. We leverage our BPR know-how and unique bottled marketing and operation expertise to help business leaders receive deeper insights using Gen AI. Embrace the AI-assisted revolution with TFS custom deep prompts, GPTs for ChatGPT Team, and individualized consulting to improve efficiency, effectiveness, and quality. Our team combines decades of expertise with a pioneering spirit. We understand AI is a transformative technology, but we also recognize the irreplaceable value of human insight and oversight. Our offerings blend the strengths of people and machines through prompt engineering, consulting, and subscription-based access to our AI knowledge base. Depending on your specific needs, one of our experts will lead your project. Contact us at info@TheFusionSyndicate.com today to learn more. ***Privacy Statement*** We value your privacy and are committed to keeping your personal information secure. We will never sell your data to a third party and will only use it to contact you regarding our services. Rest assured that we will handle your information with the utmost care and confidentiality.
Bimeda is an Ireland-based company that develops, manufactures and markets veterinary and animal care products.
Harbinger is a commercial electric vehicle (EV) company on a mission to transform an industry starving for innovation. Harbingers best-in-class team of EV, battery, and drivetrain experts have pooled their deep experience to support the growing demand for medium-duty EVs. Leveraging a foundation of proprietary, in-house developed vehicle technologies designed specifically for commercial vehicles, Harbinger is bringing a first-of-its-kind EV platform to market, priced for zero acquisition premium. Harbinger: familiar form, revolutionary foundation.
Overview Honeybear Marketing LLC is a vertically integrated premium apple growing packing and marketing organization based in Washington State. We are Growers, Packers and Shippers of premium Washington State, Midwest and Southern Hemisphere apples and pears distributed throughout the United States and to international markets. With our "Premium Fresh Fruit" programs, we provide our customers with a dual hemisphere supply base in both the Northern and Southern Hemisphere. Today, through the exclusive arrangements with our growing partners in Chile and New Zealand, our customers enjoy the supply assurance of receiving premium fresh fruit year round. Honeybear Marketing is the sales and marketing company for 5 independently owned growing and packing entities in Washington State, Minnesota and Wisconsin. Our sales offices are located in Brewster WA, Yakima WA and Elgin, MN. Honeybear Marketing LLC is a wholly owned subsidiary of Wescott Agri Products
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.